HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stanley N Caroff Selected Research

Tardive Dyskinesia

2/2022An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia.
1/2022Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
6/2021Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study.
5/2021Effect of Varenicline on Tardive Dyskinesia: A Pilot Study.
11/2020Recent Advances in the Pharmacology of Tardive Dyskinesia.
11/2020Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.
5/2020RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.
1/2020Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool.
1/2020Revisiting amantadine as a treatment for drug-induced movement disorders.
1/2019Overcoming barriers to effective management of tardive dyskinesia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stanley N Caroff Research Topics

Disease

20Tardive Dyskinesia
02/2022 - 12/2005
15Schizophrenia (Dementia Praecox)
05/2021 - 06/2005
10Dyskinesias (Dyskinesia)
02/2022 - 05/2006
8Movement Disorders (Movement Disorder)
02/2022 - 01/2002
8Parkinsonian Disorders (Parkinsonism)
01/2022 - 03/2007
8Neuroleptic Malignant Syndrome
05/2020 - 11/2002
7Psychomotor Agitation (Akathisia)
01/2022 - 12/2005
6Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2002
5Dystonia (Limb Dystonia)
01/2022 - 10/2008
5Catatonia
01/2020 - 01/2010
4Hyperthermia
02/2021 - 09/2011
3Mental Disorders (Mental Disorder)
01/2022 - 01/2018
3Major Depressive Disorder (Major Depressive Disorders)
11/2020 - 01/2020
2Mood Disorders (Mood Disorder)
01/2022 - 11/2020
2Bipolar Disorder (Manic Depressive Psychosis)
11/2020 - 01/2011
2Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2002
2Hyperkinesis
01/2019 - 01/2018
1Tremor (Tremors)
01/2022
1Drug-Induced Dyskinesia (Dyskinesia, Drug Induced)
05/2021
1Coma (Comas)
02/2021
1Rhabdomyolysis
02/2021
1Drug-Induced Akathisia (Akathisia, Drug Induced)
01/2020
1Psychomotor Disorders
01/2018
1Tachypnea
09/2011
1Tachycardia (Tachyarrhythmias)
09/2011
1Drug-Related Side Effects and Adverse Reactions
02/2010
1Dystonic Disorders (Writer's Cramp)
12/2008
1Freeman-Sheldon syndrome
09/2006
1Substance-Related Disorders (Drug Abuse)
12/2005
1Cocaine-Related Disorders (Cocaine Addiction)
06/2005
1Hyperventilation
09/2002

Drug/Important Bio-Agent (IBA)

28Antipsychotic Agents (Antipsychotics)IBA
02/2022 - 01/2002
5Pharmaceutical PreparationsIBA
01/2022 - 02/2011
3Dopamine Receptors (Dopamine Receptor)IBA
01/2022 - 01/2018
2AntiemeticsIBA
01/2022 - 01/2020
2Dopamine (Intropin)FDA LinkGeneric
01/2022 - 11/2020
2Cholinergic Agents (Cholinergics)IBA
05/2021 - 03/2007
2Tetrabenazine (Nitoman)FDA Link
05/2020 - 01/2018
2valbenazineIBA
05/2020 - 01/2018
2Dopamine AntagonistsIBA
09/2017 - 09/2011
2Cholinergic Antagonists (Anticholinergics)IBA
12/2008 - 12/2005
2Haloperidol (Haldol)FDA LinkGeneric
12/2008 - 06/2005
1Valproic Acid (Depakote)FDA LinkGeneric
01/2022
1LithiumIBA
01/2022
1pimavanserinIBA
01/2022
1Excipients (Suspending Agents)IBA
01/2022
1lumateperoneIBA
01/2022
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2021
1Varenicline (Chantix)FDA Link
05/2021
1Prescription DrugsIBA
02/2021
1Psychotropic Drugs (Psychoactive Drugs)IBA
02/2021
1Benztropine (Benzatropine)FDA LinkGeneric
07/2020
1deutetrabenazineIBA
05/2020
1Reserpine (Serpasil)FDA Link
05/2020
1Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
05/2020
1AminesIBA
01/2020
1Amantadine (Aman)FDA LinkGeneric
01/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2020
1tyramine-deoxysorbitolIBA
01/2020
1NexusIBA
01/2016
1Creatine Kinase (Creatine Phosphokinase)IBA
09/2011
1Dopamine Agonists (Dopamine Agonist)IBA
09/2011
1BenzodiazepinesIBA
03/2010
1Messenger RNA (mRNA)IBA
02/2010
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2010
1Promethazine (Promet)FDA LinkGeneric
12/2008
1ziprasidone (Geodon)FDA Link
10/2008
1Perphenazine (Trilafon)FDA LinkGeneric
10/2008
1Risperidone (Risperdal Consta)FDA LinkGeneric
10/2008
1Quetiapine Fumarate (Seroquel)FDA Link
10/2008
1Cholinesterase Inhibitors (Anticholinesterases)IBA
03/2007
1Galantamine (Galanthamine)FDA LinkGeneric
03/2007
1Metoclopramide (Reglan)FDA LinkGeneric
09/2006
1Aripiprazole (Abilify)FDA Link
06/2006
1Levodopa (L Dopa)FDA LinkGeneric
05/2006
1Donepezil (Aricept)FDA LinkGeneric
05/2006
1Cocaine (Cocaine HCl)IBA
06/2005
1Olanzapine (Zyprexa)FDA Link
06/2005
1Anesthetics (Anesthetic Agents)IBA
09/2002
1Caffeine (No Doz)FDA LinkGeneric
09/2002
1EtomidateFDA LinkGeneric
09/2002
1KetamineFDA LinkGeneric
09/2002
1Clozapine (Clozaril)FDA LinkGeneric
01/2002

Therapy/Procedure

3Therapeutics
01/2022 - 06/2005
2Drug Tapering
11/2020 - 01/2018
1Nicotine Replacement Therapy
05/2021
1Communication Aids for Disabled (TDD)
01/2020
1Deep Brain Stimulation
01/2017
1Duration of Therapy
12/2005
1Critical Care (Surgical Intensive Care)
11/2002